Baxter International Inc (NYSE:BAX)
$ 33.9 -0.1 (-0.29%) Market Cap: 17.27 Bil Enterprise Value: 28.42 Bil PE Ratio: 6.52 PB Ratio: 2.11 GF Score: 75/100

Baxter International Inc at Morgan Stanley Healthcare Conference Transcript

Sep 09, 2019 / 05:05PM GMT
Release Date Price: $87.2 (-2.87%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

All right. Let's go ahead and get started here, a big room. My name is David Lewis, medical device analyst here at Morgan Stanley. It's my pleasure to have with us here members of management from Baxter as we kind of progress through the afternoon session here post-lunch. I donât see any food comas out there just yet. Well, it's my pleasure to have with us Joe Almeida, the CEO; and Clare Trachtman, VP, Investor Relations. And we're going to jump right into Q&A.

Questions & Answers

David Ryan Lewis;JosÃ
Morgan Stanley, Research Division - MD

And Joe, not to kind of engage in self-promotion of our rating to begin the year, but we talked about a couple of things as it relates to our upgrade of Baxter earlier this year. One was sort of stabilizing the core IV solutions business, the pathway to 2020 acceleration and sort of deploy the balance sheet. Could you just share with us where you think you are kind of across those 3 components here, 9 months through the year?

©

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot